Lars Wallentin, MD

The PLATO Trial (Ticagrelor vs Clopidogrel) and the Influence of Genetic Non-Responders

06/04/2012

For acute coronary syndrome patients, the PLATO trial showed that ticagrelor was superior to clopidogrel in the reduction of cardiovascular death, myocardial infarction and stroke. Dr. Wallentin discusses ticagrelor and the discovery that...

For acute coronary syndrome...

06/04/2012

Cath Lab Digest

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 13 ⁠–⁠ November 16

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

See Full Calendar

Lars Wallentin, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products